209 related articles for article (PubMed ID: 30550616)
1. Supernormal Flicker ERGs in Eyes With Central Retinal Vein Occlusion: Clinical Characteristics, Prognosis, and Effects of Anti-VEGF Agent.
Miyata R; Kondo M; Kato K; Sugimoto M; Matsubara H; Ikesugi K; Ueno S; Yasuda S; Terasaki H
Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5854-5861. PubMed ID: 30550616
[TBL] [Abstract][Full Text] [Related]
2. Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion.
Yasuda S; Kachi S; Ueno S; Piao CH; Terasaki H
Acta Ophthalmol; 2015 Sep; 93(6):e465-8. PubMed ID: 25597703
[TBL] [Abstract][Full Text] [Related]
3. Normal to supernormal 30-Hz flicker ERGs predict visual function and prognosis in central retinal artery occlusion.
Kim HM; Park KH; Woo SJ
Doc Ophthalmol; 2020 Dec; 141(3):279-292. PubMed ID: 32506269
[TBL] [Abstract][Full Text] [Related]
4. Electroretinograms and level of aqueous vascular endothelial growth factor in eyes with hemicentral retinal vein occlusion or branch retinal vein occlusion.
Yasuda S; Kachi S; Ueno S; Ushida H; Piao CH; Kondo M; Terasaki H
Jpn J Ophthalmol; 2014 May; 58(3):232-6. PubMed ID: 24668132
[TBL] [Abstract][Full Text] [Related]
5. Changes of focal macular and full-field electroretinograms after intravitreal aflibercept in patients with central retinal vein occlusion.
Nishimura T; Machida S; Hara Y
Doc Ophthalmol; 2020 Oct; 141(2):169-179. PubMed ID: 32215778
[TBL] [Abstract][Full Text] [Related]
6. Retinal function determined by flicker ERGs before and soon after intravitreal injection of anti-VEGF agents.
Terauchi G; Shinoda K; Sakai H; Kawashima M; Matsumoto CS; Mizota A; Miyake Y
BMC Ophthalmol; 2019 Jun; 19(1):129. PubMed ID: 31208350
[TBL] [Abstract][Full Text] [Related]
7. Significant correlation between electroretinogram parameters and ocular vascular endothelial growth factor concentration in central retinal vein occlusion eyes.
Yasuda S; Kachi S; Kondo M; Ushida H; Uetani R; Terui T; Piao CH; Terasaki H
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5737-42. PubMed ID: 21642626
[TBL] [Abstract][Full Text] [Related]
8. Correlation of electroretinographic and fluorescein angiographic findings in unilateral central retinal vein obstruction.
Matsui Y; Katsumi O; Mehta MC; Hirose T
Graefes Arch Clin Exp Ophthalmol; 1994 Aug; 232(8):449-57. PubMed ID: 7926880
[TBL] [Abstract][Full Text] [Related]
9. Focal macular electroretinogram in macular edema secondary to central retinal vein occlusion.
Ogino K; Tsujikawa A; Nakamura H; Miyamoto K; Murakami T; Muraoka Y; Kurashige Y; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3514-20. PubMed ID: 21398283
[TBL] [Abstract][Full Text] [Related]
10. Enhanced depth imaging optical coherence tomography of the choroid in central retinal vein occlusion.
Tsuiki E; Suzuma K; Ueki R; Maekawa Y; Kitaoka T
Am J Ophthalmol; 2013 Sep; 156(3):543-547.e1. PubMed ID: 23688711
[TBL] [Abstract][Full Text] [Related]
11. The flicker electroretinogram interocular amplitude ratio is a strong prognostic indicator of neovascularization in patients with central retinal vein occlusion.
Kuo HK; Kuo MT; Chen YJ; Wu PC; Chen CH; Chen YH
Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):185-9. PubMed ID: 19813018
[TBL] [Abstract][Full Text] [Related]
12. SCORE2 Report 2: Study Design and Baseline Characteristics.
Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; Figueroa M; Dugel PU;
Ophthalmology; 2017 Feb; 124(2):245-256. PubMed ID: 27863843
[TBL] [Abstract][Full Text] [Related]
13. Flicker electroretinograms recorded with mydriasis-free RETeval system before and after cataract surgery.
Miura G; Sato E; Yamamoto S
Eye (Lond); 2017 Nov; 31(11):1589-1593. PubMed ID: 28622319
[TBL] [Abstract][Full Text] [Related]
14. FELLOW EYE CHANGES IN PATIENTS WITH NONISCHEMIC CENTRAL RETINAL VEIN OCCLUSION: Assessment of Perfused Foveal Microvascular Density and Identification of Nonperfused Capillaries.
Pinhas A; Dubow M; Shah N; Cheang E; Liu CL; Razeen M; Gan A; Weitz R; Sulai YN; Chui TY; Dubra A; Rosen RB
Retina; 2015 Oct; 35(10):2028-36. PubMed ID: 25932560
[TBL] [Abstract][Full Text] [Related]
15. Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion.
Rayess N; Rahimy E; Ying GS; Pefkianaki M; Franklin J; Regillo CD; Ho AC; Hsu J
Am J Ophthalmol; 2016 Nov; 171():47-52. PubMed ID: 27567889
[TBL] [Abstract][Full Text] [Related]
16. Retinal Oxygen Saturation Correlates With Visual Acuity but Does Not Predict Outcome After Anti-VEGF Treatment in Central Retinal Vein Occlusion.
Jeppesen SK; Bek T
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2498-2502. PubMed ID: 28470332
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab.
Brogan K; Precup M; Rodger A; Young D; Gilmour DF
BMC Ophthalmol; 2018 Feb; 18(1):37. PubMed ID: 29426292
[TBL] [Abstract][Full Text] [Related]
18. Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion.
Ishida M; Abe S; Nakagawa T; Hayashi A
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2135-2140. PubMed ID: 28803326
[TBL] [Abstract][Full Text] [Related]
19. Multifocal electroretinographic features of central retinal vein occlusion.
Dolan FM; Parks S; Keating D; Dutton GN; Evans AL
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4954-9. PubMed ID: 14578422
[TBL] [Abstract][Full Text] [Related]
20. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
